Does PRP safe and effective in treatment of erectile dysfunction ? our intial experience

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

PACTR

Registry ID

PACTR202412601643621

Enrollment

100

Registered

2024-12-02

Start date

2020-01-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urological and Genital Diseases

Interventions

saline

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: -Male participants who were sexually active, -45_65 years old, -suffering from mild, mild to moderate or moderate ED according to IIEF-EF score after stoppage any ED treatment

Exclusion criteria

Exclusion criteria: Participants with a history of major pelvic surgery or trauma, major penile surgery or radiation, anatomical or pathological disorders impairing penile erection, low testosterone levels (lower than 300ng/dl), psychogenic ED thrombocytopenia were excluded from the study.

Design outcomes

Primary

Measure	Time frame
The primary outcome was the proportion of patients in each group attaining MCID in the IIEF-EF domain	—

Secondary

Measure	Time frame
continuation of improvement objective and subjective	—

Countries

Egypt

Contacts

Public ContactTamer Diab

lecturer at Benha faculty of medicine

Tamer.diab@fmed.bu.edu.eg00201003583264

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026